Medicaid Driving New Retail Scripts – IMS
This article was originally published in The Pink Sheet Daily
Executive Summary
Medicaid prescriptions jumped 25.4% in the 27 states, plus D.C., that expanded coverage under ACA.
You may also be interested in...
Medicaid Expansion Boosts Rx Fills 79% For High-Cost Patients – RAND Study
Diabetics who were previously uninsured boosted their rate of drug use more than individuals with other chronic diseases once they obtained coverage in 2014, study finds.
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Deal Watch: Sanofi, Boehringer Swap Side Businesses
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.